Coloplast A/S Stock
Stocks
COLO B
DK0060448595
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Nasdaq Copenhagen
11:20:00 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 417.90 DKK | -0.26% |
|
-0.41% | -23.52% |
| 09-09 | JP Morgan cuts Coloplast, puts Ambu and Elekta on negative watch - BN | FW |
| 09-09 | JP Morgan downgrades Coloplast to underweight (neutral) - BN | FW |
| Market Cap | 94.1B 14.3B 12.59B 11.93B 10.77B 20.3B 1,371B 20.56B 143B 54.93B 701B 53.69B 52.52B 2,247B | P/E 2026 * |
26.9x | P/E 2027 * | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 115B 17.4B 15.32B 14.52B 13.11B 24.7B 1,668B 25.02B 174B 66.84B 853B 65.33B 63.91B 2,734B | EV / Sales 2026 * |
3.97x | EV / Sales 2027 * | 3.69x |
| Free-Float |
63.42% | Yield 2026 * |
4.89% | Yield 2027 * | 5.2% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| COLO B | Delayed | |
CBOE
| COLOBc | Real-time | |
|
Tradegate
| CBHD | Real-time | |
|
Xetra
| CBHD | Delayed | |
|
London S.E.
| 0QBO | Delayed | |
|
Berne S.E.
| 020259063 | End-of-day quote | |
|
Boerse Muenchen
| CBHD | Real-time | |
|
Deutsche Boerse AG
| CBHD | Delayed | |
|
CBOE
| 0QBO | Real-time | |
|
OTC Markets
| CLPB.F | Delayed | |
|
Wiener Boerse
| COLO | End-of-day quote | |
|
Börse Stuttgart
| CBHD | Delayed |
Last Transcript: Coloplast A/S
| 1 day | -0.26% | ||
| 1 week | -0.41% | ||
| 1 month | -8.91% | ||
| 3 months | +12.25% | ||
| 6 months | -4.24% | ||
| Current year | -23.52% |
| 1 week | 411.9 |  | 424.2 |
| 1 month | 411.9 | | 483.5 |
| Current year | 369.7 | | 584.2 |
| 1 year | 369.7 | | 631.4 |
| 3 years | 369.7 | | 977.6 |
| 5 years | 369.7 | | 1,194 |
| 10 years | 369.7 | | 1,194 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Wood
CEO | Chief Executive Officer | 55 | 2026-04-30 |
| Director of Finance/CFO | 54 | 2005-12-31 | |
Allan Rasmussen
COO | Chief Operating Officer | 59 | 2008-09-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 79 | 2006-12-12 | |
Thomas Barfod
BRD | Director/Board Member | 56 | 2009-09-17 |
| Chairman | 58 | 2025-05-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/11/22 | Buy | Company | 27,398 | 0.0138% | ||
| 4/4/22 | Buy | Company | 393,288 | 0.1986% | ||
| 3/28/22 | Buy | Company | 3,552 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.26% | -0.41% | -23.04% | -44.10% | 14.3B | |
| -2.10% | -4.50% | -26.21% | +2.04% | 175B | |
| -0.92% | -3.37% | -9.40% | +10.12% | 111B | |
| -0.90% | +0.73% | -25.50% | +0.78% | 107B | |
| +0.69% | -2.90% | -47.25% | -11.84% | 75.31B | |
| -2.39% | -3.85% | -3.93% | +66.83% | 58.7B | |
| -1.63% | -1.93% | -4.37% | -30.76% | 49.57B | |
| +1.76% | +3.65% | +16.55% | +58.21% | 49.27B | |
| -2.11% | +0.03% | -18.27% | +19.42% | 42.02B | |
| -0.40% | -1.64% | +28.24% | -7.51% | 32.69B | |
| Average | -0.40% | -1.51% | -11.32% | +6.32% | 71.49B | |
| Weighted average by Cap. | -0.01% | -2.16% | -16.39% | +8.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.86B 4.38B 3.86B 3.66B 3.3B 6.22B 420B 6.31B 43.77B 16.84B 215B 16.46B 16.11B 689B | 30.79B 4.68B 4.12B 3.9B 3.52B 6.64B 449B 6.73B 46.7B 17.97B 229B 17.57B 17.19B 735B |
| Net income | 3.71B 564M 497M 471M 425M 801M 54.07B 811M 5.63B 2.17B 27.64B 2.12B 2.07B 88.62B | 5.84B 888M 782M 741M 669M 1.26B 85.11B 1.28B 8.86B 3.41B 43.51B 3.33B 3.26B 139B |
| Net Debt | 20.4B 3.1B 2.73B 2.59B 2.34B 4.4B 297B 4.46B 30.95B 11.91B 152B 11.64B 11.39B 487B | 19.59B 2.98B 2.62B 2.48B 2.24B 4.23B 285B 4.28B 29.71B 11.43B 146B 11.18B 10.93B 468B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | DKK 417.90 | -0.26% | 334,274 |
| 26-09-29 | DKK 419.00 | -0.43% | 279,690 |
| 26-09-28 | DKK 420.80 | +0.77% | 323,630 |
| 26-09-25 | DKK 417.60 | -0.71% | 362,766 |
| 26-09-24 | DKK 420.60 | +0.24% | 282,768 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COLO B Stock
Select your edition
All financial news and data tailored to specific country editions
